ZA923169B - Therapeutic compositions based on 1,2-dithiole-3-thione derivatives - Google Patents

Therapeutic compositions based on 1,2-dithiole-3-thione derivatives

Info

Publication number
ZA923169B
ZA923169B ZA923169A ZA923169A ZA923169B ZA 923169 B ZA923169 B ZA 923169B ZA 923169 A ZA923169 A ZA 923169A ZA 923169 A ZA923169 A ZA 923169A ZA 923169 B ZA923169 B ZA 923169B
Authority
ZA
South Africa
Prior art keywords
dithiole
therapeutic compositions
compositions based
thione derivatives
thione
Prior art date
Application number
ZA923169A
Other languages
English (en)
Inventor
Marie Odile Christen
Jean Louis Burgot
Original Assignee
Therapeutique Moderne Lab De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapeutique Moderne Lab De filed Critical Therapeutique Moderne Lab De
Publication of ZA923169B publication Critical patent/ZA923169B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA923169A 1991-05-02 1992-04-30 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives ZA923169B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105411A FR2676057B1 (fr) 1991-05-02 1991-05-02 Derives de 1,2-dithiole-3-thione, procede de preparation de ces derives, ainsi que l'utilisation de ces derives comme intermediaires de synthese ou comme medicaments.

Publications (1)

Publication Number Publication Date
ZA923169B true ZA923169B (en) 1993-11-01

Family

ID=9412462

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923169A ZA923169B (en) 1991-05-02 1992-04-30 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives

Country Status (11)

Country Link
US (2) US5470871A (xx)
EP (1) EP0576619B1 (xx)
JP (1) JP3226920B2 (xx)
AU (1) AU1768592A (xx)
DE (1) DE69201302T2 (xx)
DZ (1) DZ1576A1 (xx)
ES (1) ES2070002T3 (xx)
FR (1) FR2676057B1 (xx)
HU (1) HU225498B1 (xx)
WO (1) WO1992019613A2 (xx)
ZA (1) ZA923169B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2260128A1 (en) * 1996-07-05 1998-01-15 William G. Rice Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
US6185810B1 (en) 1997-06-18 2001-02-13 The United States Of America As Represented By The Secretary Of The Navy Method of making high temperature superconducting ceramic oxide composite with reticulated metal foam
WO2002026909A1 (en) * 2000-09-29 2002-04-04 Trustees Of Dartmouth College Compositions and methods for thionation during chemical synthesis reactions
US7012148B2 (en) * 2001-09-25 2006-03-14 Trustees Of Dartmouth College Compositions and methods for thionation during chemical synthesis reactions
KR100484526B1 (ko) * 2002-11-13 2005-04-20 씨제이 주식회사 티온 유도체, 그 제조방법 및 약제학적 조성물
US7781592B2 (en) * 2003-11-25 2010-08-24 Cj Cheiljedang Corporation Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same
KR100604261B1 (ko) * 2004-10-11 2006-07-28 재단법인서울대학교산학협력재단 신규4,5,6,7-테트라히드로-[1,2]디티올로[4,3-ｃ]피리딘-3-티온계 화합물
US20070299093A1 (en) * 2005-01-27 2007-12-27 Alma Mater Studiorum-Universitá Di Bologna Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
EA200701584A1 (ru) * 2005-01-27 2008-02-28 Альма Матер Студиорум - Университа' Ди Болонья Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
US8464813B2 (en) * 2006-06-20 2013-06-18 Atlas Copco Secoroc Llc Cutter assembly for a raise boring reamer
CN101429190B (zh) * 2007-08-24 2013-03-27 沈阳药科大学 4,5-二取代苯基-3h-1,2-二硫杂环戊烯-3-硫酮、-酮、-酮肟类衍生物及其用途
AR075713A1 (es) * 2009-03-03 2011-04-20 Du Pont Pirazoles fungicidas
RU2534525C9 (ru) * 2013-09-24 2015-02-10 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Гликозидные производные 1,2-дитиол-3-тиона или 1,2-дитиол-3-она и лекарственные средства на их основе

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE909097C (de) * 1951-02-28 1954-04-12 Wander Ag Dr A Verfahren zur Herstellung von Trithionen
US4190727A (en) * 1971-06-25 1980-02-26 Petrolite Corporation Dithioles

Also Published As

Publication number Publication date
EP0576619B1 (fr) 1995-01-25
US5750560A (en) 1998-05-12
ES2070002T3 (es) 1995-05-16
EP0576619A1 (fr) 1994-01-05
JP3226920B2 (ja) 2001-11-12
WO1992019613A3 (fr) 1993-02-18
DZ1576A1 (fr) 2002-02-17
HUT65702A (en) 1994-07-28
HU9303113D0 (en) 1994-01-28
DE69201302T2 (de) 1995-09-28
HU225498B1 (en) 2007-01-29
US5470871A (en) 1995-11-28
FR2676057B1 (fr) 1995-03-03
WO1992019613A2 (fr) 1992-11-12
AU1768592A (en) 1992-12-21
JPH06506936A (ja) 1994-08-04
FR2676057A1 (fr) 1992-11-06
DE69201302D1 (de) 1995-03-09

Similar Documents

Publication Publication Date Title
GB9321855D0 (en) 1,4-piperazine derivatives
NZ240378A (en) Substituted thiazolidinedione derivatives; pharmaceutical compositions,
EP0569493A4 (en) Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
HUT60729A (en) 3,4,n-trisubstituted-4,5-dihydro-1h-pyrazole-1-carboxamide derivatives and insecticidal compositions comprising such compounds
GB2260135B (en) Substituted 2,6-diaminotoluenes
ZA923169B (en) Therapeutic compositions based on 1,2-dithiole-3-thione derivatives
HU9302314D0 (en) 1,4-benzodioxane derivatives
AU1928792A (en) Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives
OA09716A (en) Benzoxaiole derivatives.
EP0520435A3 (en) Dc-89 derivatives
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
EP0482206A4 (en) 4,6-o-hydroxyphosphorylglucosamine derivative
HU908313D0 (en) New 15-nitro-2betha, 3betha-dihydro- and 15-nitro-2betha, 3 betha,6,7-tetrahydro-tabersonine derivatives
HU9301651D0 (en) Pyridyl-1,2,5-oxadiazole-carbonamide-2-oxide derivatives
GB2262739B (en) Benzofuranylimidazole derivatives
GB9102423D0 (en) Pryimidinyl-and triazinylsalicyl-and-picolinylaldehyde derivatives
HU9202296D0 (en) 3,4-dehydro-piperidine derivatives
ZA90301B (en) 8,9-annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
GB9322017D0 (en) 1,4-piperazine derivatives
AU2153592A (en) Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives
AU1680092A (en) 2-amido-1,2,4-triazolinone derivatives
HU9402902D0 (en) 1,2-dihydro-2-oxo-3-methyl-sulfonyl-aminomethyl-pyridine derivatives
IE901509L (en) 1,5-benzothiazepin derivatives
EP0444276A3 (en) 1,2,4-triazolyl-propanol derivatives
IE900167L (en) 8,9-ANNELATED-1,2,3,4-TETRAHYDRO-ß-CARBOLINE DERIVATIVES